Krensavage Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Krensavage Asset Management, LLC

$178 Million
Q3 2024

A detailed history of Krensavage Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 353 shares of REGN stock, worth $268,986. This represents 0.21% of its overall portfolio holdings.

Number of Shares

353

Previous 7,853 95.5%

Holding current value

$268,986

Previous $8.25 Million 95.51%

% of portfolio

0.21%

Previous 3.79%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $7.68 Million - $9.01 Million	-7,500 Reduced 95.5%	353 $371,000
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $4.1 Million - $4.97 Million	-4,641 Reduced 37.15%	7,853 $8.25 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $31.4 Million - $34.5 Million	-34,762 Reduced 73.56%	12,494 $12 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $8.26 Million - $10.1 Million	-11,932 Reduced 20.16%	47,256 $38.9 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $210,009 - $249,105	-300 Reduced 0.5%	59,188 $42.5 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $418,501 - $508,586	-615 Reduced 1.02%	59,488 $48.9 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $554,829 - $602,382	-786 Reduced 1.29%	60,103 $43.4 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $289,854 - $365,781	505 Added 0.84%	60,889 $41.9 Million
Q2 2022 Aug 16, 2022	SELL	$548.35 - $738.84 $3.56 Million - $4.8 Million	-6,496 Reduced 9.71%	60,384 $35.7 Million
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $1.31 Million - $1.54 Million	-2,200 Reduced 3.18%	66,880 $46.7 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $2.21 Million - $2.73 Million	-4,063 Reduced 5.55%	69,080 $43.6 Million
Q3 2021 Nov 16, 2021	SELL	$574.03 - $680.96 $5.14 Million - $6.1 Million	-8,961 Reduced 10.91%	73,143 $44.3 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $280,843 - $331,772	-594 Reduced 0.72%	82,104 $45.9 Million
Q1 2021 May 18, 2021	BUY	$446.73 - $548.2 $222,471 - $273,003	498 Added 0.61%	82,698 $39.1 Million
Q4 2020 Feb 17, 2021	SELL	$478.3 - $607.98 $27,741 - $35,262	-58 Reduced 0.07%	82,200 $39.7 Million
Q3 2020 Nov 17, 2020	BUY	$544.75 - $658.21 $1.4 Million - $1.69 Million	2,567 Added 3.22%	82,258 $46 Million
Q2 2020 Aug 17, 2020	SELL	$493.32 - $643.92 $3.52 Million - $4.59 Million	-7,126 Reduced 8.21%	79,691 $49.7 Million
Q1 2020 May 18, 2020	SELL	$336.18 - $494.43 $5.92 Million - $8.7 Million	-17,603 Reduced 16.86%	86,817 $42.4 Million
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $28.6 Million - $39.3 Million	104,420 New	104,420 $39.2 Million

Others Institutions Holding REGN

# of Institutions

1,530

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Account

Krensavage Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History